v3.25.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Jun. 30, 2024
Current assets:    
Cash and cash equivalents $ 15,039 $ 5,858
Prepaid expenses and other assets 791 507
R&D tax incentive receivable 4,132 9,837
Total current assets 19,962 16,202
Property, plant and equipment, net 227 472
Operating lease right-of-use assets 258 373
Total assets 20,447 17,047
Current liabilities:    
Trade and other payables 6,104 612
Accrued expenses and other current liabilities 696 4,845
Operating lease liabilities, current 184 163
Total current liabilities 6,984 5,620
Operating lease liabilities, non-current 74 210
Total liabilities 7,058 5,830
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Common stock, $0.0001 par value – 800,000,000 shares authorized; 194,379,996 and 17,642,832 shares issued and outstanding at June 30, 2025 and 2024, respectively 20 2
Preferred stock, $0.0001 par value per share, 10,000,000 shares authorized; no shares issued or outstanding at June 30, 2025 and 2024, respectively
Additional paid-in capital 174,049 125,218
Accumulated deficit (157,556) (110,671)
Foreign currency translation reserve (3,124) (3,332)
Total stockholders’ equity 13,389 11,217
Total liabilities and stockholders’ equity $ 20,447 $ 17,047